Deficiencies in CD4+ and CD8+ T cell subsets in ataxia telangiectasia

Clinical and Experimental Immunology

Volumn 129, Issue 1, 2002, Pages 125-132

  Schubert, R ^a,b   Reichenbach, J ^a   Zielen, S ^a  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Ataxia telangiectasia; CD45RA+ (naive) lymphocytes; CD4+ cells; CD8+ cells; T cell activation

Indexed keywords

CD16 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CD56 ANTIGEN; CD8 ANTIGEN; INTERFERON; PHORBOL DIBUTYRATE; PHYTOHEMAGGLUTININ; T LYMPHOCYTE RECEPTOR;

ADOLESCENT; ADULT; ARTICLE; ATAXIA TELANGIECTASIA; CELL KINETICS; CELLULAR DISTRIBUTION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HOST RESISTANCE; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; LYMPHOCYTE CULTURE; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; LYMPHOCYTOPOIESIS; MALE; MEMORY CELL; NATURAL KILLER CELL; POLYCLONAL ACTIVATION; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION;

ADOLESCENT; ADULT; ANTIBODY FORMATION; ANTIGENS, CD45; ATAXIA TELANGIECTASIA; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CHILD; CHILD, PRESCHOOL; CYTOKINES; FEMALE; HUMANS; IMMUNITY, CELLULAR; IMMUNOPHENOTYPING; INTERFERON TYPE II; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; MALE; PROTEIN ISOFORMS; T-LYMPHOCYTE SUBSETS;

EID: 0036380877     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2002.01830.x     Document Type: Article

References (38)

1. Gatti RA, Boder E, Vinters HV, Sparkes RS, Norman A, Lange K. Ataxia-telangiectasia: an interdisciplinary approach to pathogenesis. Medicine 1991; 70:99-117.
2. Lavin F, Shiloh Y. The genetic defect in ataxia-telangiectasia. Annu Rev Immunol 1997; 15:177-202.
3. Savitsky K, Bar-Shira A, Gilad S et al. A single ataxia-telangiectasia gene with a product similar to PI-3 kinase. Science 1995; 268:1749-53.
4. Meyn MS. Ataxia-telangiectasia and cellular responses to DNA damage. Cancer Res 1995; 55:5991-6001.
5. Lavin F, Shiloh Y. Ataxia-telangiectasia: a multifaceted genetic disorder associated with defective signal transduction. Curr Opin Immunol 1996; 8:459-64.
6. Kastan MB, Lim D. The many substrates and functions of ATM. Nat Rev Mol Cell Biol 2000; 1:179-86.
7. Morrell D, Cromartie E, Swift M. Mortality and cancer incidence in 263 patients with ataxia-telangiectasia. J Nat Cancer Inst 1986; 77:89-92.
8. McFarlin DE, Strober W, Waldmann TA. Ataxia-telangiectasia. Medicine 1972; 51:281-314.
9. Oxelius VA, Berkel A, Hanson LA. IgG2 deficiency in ataxia telangiectasia. N Engl J Med 1982; 306:515-7.
10. Levis WR, Dattner AM, Shaw JS. Selective defects in T cell function in ataxia-telangiectasia. Clin Exp Immunol 1979; 37:44-9.
11. Nelson DL, Biddison WE, Shaw S. Defective in vitro production of influenza virus-specific cytotoxic lymphocytes in ataxia-telangiectasia. J Immunol 1983; 130:2629-34.
12. Paganelli R, Cabobianchi MR, Ensoli B et al. Evidence that defective gamma interferon production in patients with primary immunodeficiencies is due to intrinsic incompetence of lymphocytes. Clin Exp Immunol 1988; 72:124-9.
13. Khanna KK, Yan J, Watters D et al. Defective signaling through the B cell antigen receptor in Epstein-Barr virus-transformed ataxia telangiectasia cells. J Biol Chem 1997; 272:9489-95.
14. + lymphocytes in patients with ataxia-telangiectasia. J Clin Immunol 1992; 12:84-91.
15. Clement LT. Isoforms of the CD45 common leukocyte antigen family: marker of human T-cell differentiation. J Clin Immunol 1992; 12:1-10.
16. Yan M, Qiang W, Liu N, Shen J, Lynn WS, Wong PKY. The ataxia-telangiectasia gene product may modulate DNA turnover and control cell fate by regulating cellular redox in lymphocytes. FASEB J 2001; 15:1132-8.
17. Borghesani PR, Alt FW, Bottaro A et al. Abnormal development of Purkinje cells and lymphocytes in Atm mutant mice. Proc Natl Acad Sci USA 2000; 97:3336-41.
18. Barlow C, Hirotsune S, Paylor R et al. Atm-deficient mice, a paradigm of ataxia telangiectasia. Cell 1996; 86:159-71.
19. Xu Y, Ashley T, Brainerd EE, Bronson RT, Meyn S, Baltimore D. Targeted disruption of ATM leads to growth retardation, chromosomal fragmentation during meiosis, immune defects, and thymic lymphoma. Genes Dev 1996; 10:2411-22.
20. -/- mice by a functional TCRαβ transgene. J Immunol 2000; 164:345-9.
21. Primary Immunodeficiency Diseases. Report of a WHO scientific group. Clin Exp Immunol 1997; 40:166-96.
22. Hecht F, Hecht BK. Cancer in ataxia-telangiectasia patients. Cancer Genet Cytogenet 1990; 46:9-19.
23. Paganelli R, Capobianchi MR, Matricardi PM et al. Defective interferon-gamma production in ataxia-telangiectasia. Clin Immunol Immunopathol 1984; 32:387-91.
24. Peterson RDA, Funkhouser JD. Speculations on ataxia-telangiectasia: defective regulation of the immunoglobulin gene superfamily. Immunol Today 1989; 10:313-4.
25. Waldmann TA, Broder S, Goldmann CK, Frost K, Korsmeyer SJ, Medici MA. Disorders of B cells and helper T cells in the pathogenesis of the immunoglobulin deficiency of patients with ataxia-telangiectasia. J Clin Invest 1983; 71:282-95.
26. Fiorilli M, Busiconi L, Pandolfi F, Paganelli R, Russo G, Aiuti F. Heterogeneity of immunological abnormalities in ataxia-telangiectasia. J Clin Immunol 1983; 3:135-41.
27. Bell EB, Sparshott SM. Interconversion of CD45R subsets of CD4 T cells in vivo. Nature 1990; 348:163-6.
28. +) cells. Cell Immunol 1996; 173:282-6.
29. Borrego F, Alonso MC, Galiani MD et al. NK phenotypic markers and IL2 response in NK cells from elderly people. Exp Gerontol 1999 1985; 34:253-65.
30. Yarchoan R, Kurman CC, Nelson DL. Defective specific antiinfluenza virus antibody production in vitro by lymphocytes from patients with ataxia-telangiectasia. In: Gatti RA, Swift M, eds. Ataxia-telangiectasia. Genetics, neuropathology, and immunology of a degenerative disease of childhood. New York, Alan R. Liss, 1985:315.
31. Kondo N, Inoue R, Nishimura S et al. Defective calcium-dependent signal transduction in T lymphocytes of ataxia-telangiectasia. Scand J Immunol 1993; 38:45-8.
32. Meydan D, Hellgren D, Lambert B. Variation in the frequency of T-cell receptor β/γ-interlocus recombination in long-term cultures of non-irradiated and X- and γ-irradiated human lymphocytes. Int J Radiat Biol 1998; 74:697-703.
33. Retiere C, Halary F, Peyrat MA, Le Deist F, Bonneville M, Hallet MM. The mechanism of chromosome 7 inversion in human lymphocytes expressing chimeric gamma beta TCR. J Immunol 1999; 15:903-10.
34. Hinz T, Allam A, Wesch D, Schindler D, Kabelitz D. Cell-surface expression of transrearranged Vγ-Cβ T-cell receptor chain in healty donors and in ataxia telangiectasia patients. Br J Haematol 2000; 109:201-10.
35. Lim DS, Kirsch DG, Canman CE et al. ATM binds to β-adaptin in cytoplasmic vesicles. Proc Natl Acad Sci USA 1998; 95:10146-51.
36. Watters D, Khanna KK, Beamish H et al. Cellular localisation of the ataxia-telangiectasia (ATM) gene product and discrimination between mutated and normal forms. Oncogene 1997; 14:1911-21.
37. Fukao T, Kaneko H, Birrell G et al. ATM is upregulated during the mitogenic response in peripheral blood mononuclear cells. Blood 1999; 94:1998-2006.
38. Rivero-Carmena M, Porras O, Pelaez B, Pacheco-Castro A, Gatti RA, Regueiro JR. Membrane and transmembrane signaling in Herpesvirus saimiri-transformed human CD4 (+) and CD8 (+) T lymphocytes is ATM-independent. Int Immunol 2000; 12:927-35.